Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Using the American Heart Association’s Life’s Essential 8 model, researchers indicated that preventative action early in life can reduce chances of developing cardiovascular disease later.

Cardiovascular Health in Youth Linked to Lower Disease Risk in Adulthood

Simple choices like improving diet and increasing exercise can influence a healthy individual’s risk of developing cardiovascular disease.

Study Indicates Lifestyle Choices are Correlated with Cardiovascular Disease Risk

A secondary analysis of the data collected by the DASH-Sodium trial indicates that dieting and sodium intake limits are additive in their effects on ASCVD risk.

Limiting Sodium Intake Can Reduce Atherosclerotic Cardiovascular Disease Risk

Orchestra BioMed’s Breakthrough Device designation could apply to nearly 8 million patients with uncontrolled hypertension and increased cardiovascular risk

FDA Awards Breakthrough Device Designation to AVIM Therapy for Hypertension

Anita Radhakrishnan, MD, leads a community screening effort to detect early heart disease in underserved populations in Pittsburgh.

Community Echocardiogram Program Reveals Cardiac Risks, with Anita Radhakrishnan, MD

Anemia can moderate the association between both conditions, increasing the risk of atherosclerotic cardiovascular disease.

Anemia Exacerbates Adverse Effects of Hypertension and Blood Urea Nitrogen

Label updates simplify twice-yearly echo monitoring for eligible patients in the maintenance phase and expand eligibility with reduced contraindications.

FDA Updates Mavacamten Label in Obstructive Hypertrophic Cardiomyopathy

Radhakrishnan describes a unique initiative in Pittsburgh promoting health equity and closing the gap in cardiovascular health disparities.

Scaling Health Equity in Heart Failure, With Anita Radhakrishnan, MD

This episode spotlights a pair of studies examining use of semaglutide from the American College of Cardiology's 2025 Scientific Sessions.

Diabetes Dialogue: SCORE, Semaglutide, and ACC Wrap-up

Individuals treated with ezetimibe shortly after myocardial infarction experience an improved prognosis versus those who receive delayed treatment or none at all.
